http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016155769-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa51640fede0c1336040e2ffdbd631f1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06 |
| filingDate | 2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53e1f99b9da0aef146cbe25bbbd7b43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfd7c0fa07bc1e3cbf60e0b3e7af086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33675d46e835643e4e0cb49420a0b976 |
| publicationDate | 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016155769-A |
| titleOfInvention | PSF1 gene expression inhibitor |
| abstract | [PROBLEMS] To provide a more effective cancer treatment method through PSF1 gene expression suppression activity. In HPLC analysis under the following conditions (A) to (F), component (I) having a peak at a retention time of 11.1 minutes and / or component having a peak at a retention time of 14.6 minutes Composition containing (II) and having PSF1 gene expression inhibitory activity: (A) HPLC column: column of 4.6 mm inner diameter and 150 mm length packed with octadecylated silica gel carrier (particle diameter 3 μm) (B) HPLC column Oven temperature: 40 ° C. (C) Flow rate: 0.8 ml / min (D) Detection: 190 to 400 nm (E) Mobile phase: (a) Methanol and (b) 10 mM ammonium formate aqueous solution (F) Gradient condition: 85% The mixed solvent of (a) and 15% (b) is held for 5 minutes, and then the concentration of (a) in the mixed solvent is increased linearly from 85% to 100% over 15 minutes. The concentration of (a) maintained at 100%. [Selection figure] None |
| priorityDate | 2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.